Sign in
Not yet recruitingNo phase

The Effects of Su Jok Therapy in Rheumatoid Arthritis

Key facts

Who runs it
Emine Karaca
Where
Türkiye1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
90 people, planned
Started
10 Nov 2026
Expected to end
31 May 2027
Type of study
Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • SU-JOK
  • Placebo
Record updated
16 November 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • Being 18 years of age or older,
  • Being a female or male patient,
  • Having been diagnosed with rheumatoid arthritis by a rheumatologist for at least six months,
  • Being hospitalized in the rheumatology department,
  • Having no physical disability that would prevent the application of Su Jok therapy,
  • Receiving a similar treatment protocol for rheumatoid arthritis,
  • Being able to read and write in Turkish,
  • Being able to communicate,
  • Voluntarily agreeing to participate in the study and providing written informed consent

Who cannot take part

  • Receiving physical therapy or any other alternative treatment during the study period,
  • Using sleeping medication,
  • Having previously participated in a similar study or research project
  • Having a psychiatric disorder or cognitive impairment,
  • Having any condition that compromises skin integrity on the hands or feet (e.g., burns, ulcers, or wounds)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Rhumatoid arthisis

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Rheumatoid arthritis (RA) is a chronic joint disease that develops when the immune system mistakenly attacks the body's own joints. The small joints of the hands and feet are most commonly affected, resulting in joint pain, swelling, and tenderness. Over time, permanent joint damage may occur, making it difficult for individuals to perform their daily activities. Rheumatoid arthritis may affect not only the joints but also other organs, such as the heart and lungs, in some individuals. Therefore, it is considered a health condition that can affect multiple body systems. It is more common in women than in men and is the most prevalent inflammatory joint disease among adults.

Read full original descriptionShow less

Rheumatoid arthritis is highly prevalent worldwide, affecting approximately 0.5-1% of the population. According to the 2021 Global Burden of Disease (GBD) data, approximately 17.6 million people worldwide were living with rheumatoid arthritis in 2020, and the prevalence of the disease has increased substantially since 1990.

In the early stages of the disease, symptoms are generally mild and nonspecific. Individuals may experience fatigue, weakness, and loss of appetite, along with joint pain. Diagnosis can be challenging during this period. As the disease progresses, characteristic clinical manifestations become more pronounced, and joint involvement typically develops symmetrically, particularly affecting the joints of the hands, wrists, knees, and feet.

The exact cause of rheumatoid arthritis remains unknown. However, research suggests that genetic predisposition, hormonal factors, and environmental factors may contribute to its development. The disease can adversely affect not only physical health but also psychological well-being and quality of life, requiring patients to make changes to their daily routines and lifestyle habits.

The 3 groups in the trial

  • Intervention GroupTreatment being tested

    The reflection points corresponding to the anatomical regions affected by rheumatoid arthritis will be identified on the yin-yang surfaces of the hands.The reflection points corresponding to the anatomical regions affected by rheumatoid arthritis will be identified on the yin-yang surfaces of the hands.A Su Jok probe will be used to identify the points, and the pressure application will be standardized. To confirm the correct location, participants will be asked whether they experience pain, tension, or a pulling sensation during the application. Once the point has been identified, the researcher will apply massage for three minutes. Subsequently, viable buckwheat seeds that retain their germination capacity will be secured to the designated points using adhesive tape and left in place for 10 hours. The intervention will be scheduled for 22:00, before the patient's bedtime, when the clinical environment is relatively quiet. The adhesive tape will be removed when the patient wakes up.

    Treatment: SU-JOK

  • Placebo GroupPlacebo, for comparison

    Reflection points corresponding to the relevant anatomical regions will be identified on the yin-yang areas of the hands. A Su Jok probe will be used to identify the points, and the pressure application will be standardized. To confirm the correct location, participants will be asked whether they experience pain, tension, or a pulling sensation during the application. To maintain consistency in the intervention procedures, the researcher will also apply massage to the identified points for three minutes. Following the massage, small rounded pieces of Styrofoam, similar in size and appearance to buckwheat seeds but without pressure-stimulating properties, will be secured to the identified points using adhesive tape. To ensure consistency with the actual intervention group, the procedure will be performed at 22:00, and the adhesive tape will remain in place for 10 hours. The tape will be removed when the patient wakes up. This procedure will be repeated consecutively for three days.

    Treatment: Placebo

  • Control GroupNo study treatment, for comparison

    Participants in the control group will receive no additional intervention other than the routine treatment protocol provided by the hospital.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
THE EFFECT OF SU JOK APPLİCATİON ON SLEEP QUALİTY, FATİGUE LEVELS, AND FUNCTİONAL CAPACİTY İN INDİVİDUALS WİTH RHEUMATOİD ARTHRİTİS
Criteria questions
Built from NCT07937878, who can take part
Record updated
16 November 2026